Lucigen Earns President’s ‘E’ Award
In addition to being awarded a Governor’s Export Award, Lucigen was recently honored with the 2017 President’s “E” Award, the highest recognition honoring a U.S. entity for significant contributions to…
Category Archives: Biotech
Lucigen Earns Export Award
Lucigen was recently awarded a Governor’s Export Award at the 53rd Annual Wisconsin International Trade Conference for its extraordinary results in international markets and elevating Wisconsin’s competitiveness in the global…
Cellular Logistics Pursuing Commercialization
Story provided by Alex Moe, WisBusiness.com One of the finalists in the Governor’s Business Plan Contest, Cellular Logistics, is making another run at the top prize as it pursues commercialization…
CDI Signs Two Deals
Cellular Dynamics International announced recently that it has signed a distribution agreement with STEMCELL Technologies and a collaboration agreement with the Harvard Stem Cell Institute (HSCI). According to a release,…
Cellectar Adds Two to Board
Cellectar Biosciences added Douglas Swirsky and Frederick Driscoll to its board of directors, the company announced recently. Swirsky is the president and CEO of GenVec and has worked at Stifel Nicolaus…
Lucigen Partners With Illumina
Lucigen announced recently it has partnered with Illumina to be the sole distributor of the entire Epicentre Technologies product line. Terms of the deal were not disclosed. The product line…
Cologuard Included in Star Ratings
The Centers for Medicare and Medicaid Services (CMS) is including Exact Sciences’ Cologuard in the 2018 Medicare Advantage Star Ratings program, the company announced recently. “We are pleased that Cologuard has…
Cellectar to Begin Phase II Trial
Cellectar Biosciences announced today its initiation of a Phase II clinical study of CLR 131 in patients with multiple myeloma and other hemotologic malignancies. According to a release, the study…
MVI Expands Clinical Trial
Madison Vaccines Incorporated’s clinical trial for metastatic prostate cancer is expanding to the University of Washington, its third site, the company announced recently. According to a release, MVI-118 is being explored for…
Cellectar Earns Japanese Patent
Cellectar Biosciences announced today the Japanese Patent Office has granted a composition of matter patent for its optical imaging phospholipid drug conjugates (PDCs), CLR 1501 and CLR 1502. “This patent…
